All In Biotech

Drug Trial Radar · NCT07845578

A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight

An Investigation of the Effect of High Dose s.c. Semaglutide on Gastric Emptying in Participants With Obesity

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Sep 25, 2026

Primary completion

Sep 11, 2027

Study completion Sep 11, 2027

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Sep 29, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to determine the effect of semaglutide on gastric emptying in people with obesity. Participants will receive either semaglutide or placebo, and the treatment assigned will be decided by chance. Semaglutide is a medicine that doctors can already prescribe, while placebo contains no active medicine.

Conditions

  • Obesity
  • Overweight

Interventions

  • SemaglutideDrug

    Semaglutide will be administered in the thigh, abdomen, or upper arm of body part.

  • Placebo semaglutideDrug

    Placebo matched to semaglutide will be administered in the thigh, abdomen, or upper arm of body part.

  • ParacetamolDrug

    Paracetamol is administered orally as part of a standardised meal to assess gastric emptying through pharmacokinetic evaluation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AUC,para: The area under the paracetamol plasma concentration-time curve following a standardised mealTime frame: Day 177

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Medical University of Graz

    Graz, Austria · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.